Abstract
Merkel cell carcinoma (MCC) is a rare, highly malignant carcinoma of the neuroendocrinological system (Bayrou et al., J Am Acad Dermatol 24:198–207, 1992). It is a fast-growing, aggressive tumor with a high rate of local recurrence and early metastases. A radical surgical procedure is the therapy of choice. In case of lymph node metastases, regional lymphadenectomy is mandatory. Sentinel lymph node (SLN) mapping is a standard diagnostic technique to detect micrometastases in certain patients with malignant melanoma and breast cancer. The question is, can the SLN technique provide information as a prognostic factor and can the prognosis of the MCC be improved by detecting micrometastases in SLN at an early stage?
Similar content being viewed by others
References
Allen PJ, Zhang ZF, Coit DG (1999) Surgical management of Merkel cell carcinoma. Ann Surg 229:97–105
Bayrou O, Avril MF, Charpentier P et al (1992) Primary neuroendocrine carcinoma of the skin: clinicopathological study of 18 cases. J Am Acad Dermatol 24:198–207
Bickle K, Glass LF, Messina JL, Fenske NA, Siegrist K (2004) Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg 23(1):46–53
Bielamowicz S, Smith D, Abemayor E (1994) Merkel cell carcinoma: an aggressive skin neoplasm. Laryngoscope 104:528–532
Blom A, Kolb F, Lumbroso J, Duvillard P, Mamelle G, Ricard M, Spatz A, Petrow P, Margulis A, Avril MF (2003) Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Ann Dermatol Venereol 130(4):17–22
Brady MS (2004) Currant management of patients with Merkel cell carcinoma. Dermatol Surg 30:321–325
Hill AD, Brady MS, Coit DG (1999) Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 86:518–521
Meeuwissen JA, Bourne RG, Kearsley JH (1995) The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 31:325–331
Rodrigues LK, Leong SP, Kashani-Sabet M, Wong JH (2001) Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol 45(2):303–308
Smith DE, Bielamowicz S, Kagan AR, Anderson PJ, Peddada AV (1995) Cutaneous neuroendocrine (Merkel cell) carcinoma: a report of 35 cases. Am J Clin Oncol 18:199–203
Su LD, Fullen DR, Lowe L, Uherova P, Schnitzer B, Valdez R (2002) CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 24(4):289–293
Toker C (1972) Trabecular carcinoma of the skin. Arch Dermatol 105:107–110
Yiengpruksawan A, Croit DG, Thaler HT, Urmacher C, Knapper WK (1991) Merkel cell carcinoma: prognosis and management. Arch Surg 126:1514–1519
McAfee WJ, Morris CG, Mendenhall CM, Werning JW, Mendenhall NP, Mendenhall WM (2005) Merkel cell carcinoma: treatment and outcomes. Cancer 104(8):1761–1764
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liebau, J., Arens, A., Schwipper, V. et al. Sentinel lymph node mapping for patients with Merkel cell carcinoma—experience of 5 years. Eur J Plast Surg 29, 107–109 (2006). https://doi.org/10.1007/s00238-006-0047-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00238-006-0047-0